CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Eli Lilly CEO: GLP-1 oral pill category is 'expansionary' and is 'not cannibalizing Zepbound'
Posted
August 5, 2026
Views
670
Likes
8
Comments
1
Engagement
August 5, 2026
670
8
1
1.34%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
0:48Now PlayingDavid Ricks, Eli Lilly chairman and CEO, joins ‘Squawk Box’ to discuss second-quarter earnings and revenue that easily beat estimates and hiked its full-year sales outlook, drug pricing, how oral therapies have expanded the market, and more.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
